PROVENTION BIO INC's ticker is PRVB and the CUSIP is 74374N102. A total of 108 filers reported holding PROVENTION BIO INC in Q4 2020. The put-call ratio across all filers is 3.86 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $2,229,250 | +37.1% | 92,500 | -39.9% | 0.07% | +27.6% |
Q4 2022 | $1,625,560 | +134.9% | 153,790 | +0.1% | 0.06% | +123.1% |
Q3 2022 | $692,000 | +12.5% | 153,690 | 0.0% | 0.03% | +23.8% |
Q2 2022 | $615,000 | -33.2% | 153,690 | +22.3% | 0.02% | -25.0% |
Q1 2022 | $920,000 | +34.1% | 125,620 | +3.0% | 0.03% | +47.4% |
Q4 2021 | $686,000 | -10.9% | 121,995 | +1.4% | 0.02% | -17.4% |
Q3 2021 | $770,000 | -17.3% | 120,345 | +8.9% | 0.02% | -17.9% |
Q2 2021 | $931,000 | +3.9% | 110,465 | +29.4% | 0.03% | -3.4% |
Q1 2021 | $896,000 | -10.5% | 85,335 | +44.4% | 0.03% | -14.7% |
Q4 2020 | $1,001,000 | +33.1% | 59,090 | +0.8% | 0.03% | +13.3% |
Q3 2020 | $752,000 | -9.7% | 58,640 | -0.7% | 0.03% | -18.9% |
Q2 2020 | $833,000 | +17.8% | 59,040 | -23.2% | 0.04% | -11.9% |
Q1 2020 | $707,000 | -41.0% | 76,880 | -4.4% | 0.04% | -17.6% |
Q4 2019 | $1,198,000 | +154.9% | 80,385 | +16.7% | 0.05% | +121.7% |
Q3 2019 | $470,000 | -33.0% | 68,900 | +18.9% | 0.02% | -36.1% |
Q2 2019 | $701,000 | – | 57,950 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MORGAN JESS S & CO INC | 217,050 | $2,278,000 | 1.60% |
Perceptive Advisors | 2,852,058 | $29,932,000 | 0.38% |
683 Capital Management, LLC | 630,000 | $6,612,000 | 0.35% |
ADVISORY RESEARCH INC | 237,500 | $2,493,000 | 0.18% |
GILDER GAGNON HOWE & CO LLC | 3,109,874 | $32,638,000 | 0.18% |
RICE HALL JAMES & ASSOCIATES, LLC | 247,195 | $2,594,000 | 0.08% |
Virtus ETF Advisers LLC | 16,158 | $170,000 | 0.07% |
Walleye Capital LLC | 103,823 | $1,090,000 | 0.06% |
OCCUDO QUANTITATIVE STRATEGIES LP | 22,755 | $239,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 29,384 | $308,000 | 0.05% |